Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedNov 28, 2022
DataAggregated Company Financials
Companies25
  • 7D0.7%
  • 3M-2.9%
  • 1Y5.3%
  • YTD3.0%

In the last week, the Pharma industry is flat overall, with Alliance Pharma standing out by going down 27%. The past year has been better, since the industry has gained 5.3% in that time. Earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 28 Nov 2022UK£237.5bUK£80.1bUK£6.3b33.2x37.5x3x
Wed, 26 Oct 2022UK£217.4bUK£80.0bUK£3.7b22.2x59.1x2.7x
Fri, 23 Sep 2022UK£216.8bUK£80.8bUK£3.7b14.3x59x2.7x
Sun, 21 Aug 2022UK£244.7bUK£78.8bUK£3.7b14.8x65.5x3.1x
Tue, 19 Jul 2022UK£272.4bUK£75.6bUK£4.6b16.1x59.6x3.6x
Thu, 16 Jun 2022UK£251.7bUK£75.0bUK£4.6b15.8x55.2x3.4x
Sat, 14 May 2022UK£260.9bUK£74.5bUK£4.6b16.3x57.1x3.5x
Mon, 11 Apr 2022UK£275.1bUK£66.8bUK£4.8b20.5x57.2x4.1x
Wed, 09 Mar 2022UK£226.4bUK£66.7bUK£4.7b24.2x47.7x3.4x
Fri, 04 Feb 2022UK£227.4bUK£61.2bUK£5.6b31.5x40.4x3.7x
Sun, 02 Jan 2022UK£234.6bUK£61.3bUK£5.6b32.5x41.7x3.8x
Tue, 30 Nov 2021UK£225.3bUK£61.8bUK£5.7b29.7x39.8x3.6x
Thu, 28 Oct 2021UK£231.9bUK£58.3bUK£7.5b26.4x31x4x
Sat, 25 Sep 2021UK£227.7bUK£58.4bUK£7.5b29.3x30.2x3.9x
Mon, 23 Aug 2021UK£230.4bUK£58.1bUK£7.5b28.3x30.7x4x
Sat, 10 Jul 2021UK£204.4bUK£58.1bUK£7.5b26.5x27.2x3.5x
Fri, 02 Apr 2021UK£175.1bUK£56.2bUK£8.5b23.1x20.6x3.1x
Mon, 04 Jan 2021UK£179.2bUK£57.4bUK£8.2b25.7x21.9x3.1x
Thu, 08 Oct 2020UK£199.3bUK£57.9bUK£8.4b41.1x23.7x3.4x
Wed, 01 Jul 2020UK£205.7bUK£59.5bUK£8.5b45.3x24.1x3.5x
Sat, 04 Apr 2020UK£181.5bUK£59.1bUK£6.8b19.1x26.8x3.1x
Tue, 07 Jan 2020UK£200.5bUK£55.7bUK£5.9b18.4x33.8x3.6x
Price to Earnings Ratio

29.6x


Total Market Cap: UK£196.7bTotal Earnings: UK£6.6bTotal Revenue: UK£56.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 36.8x202020212022
Current Industry PE
  • Investors are relatively neutral on the British Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 36.8x.
  • The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.33%
Healthcare0.72%
Pharma0.70%
Pharma0.70%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GSK GSKUK£13.921.8%
+UK£971.6m
-26.3%PE12.7x
AZN AstraZenecaUK£109.540.3%
+UK£526.8m
30.2%PE100.6x
HIK Hikma PharmaceuticalsUK£15.236.6%
+UK£207.0m
-33.1%PE11.7x
DPH Dechra PharmaceuticalsUK£27.621.2%
+UK£36.4m
-45.4%PE54x
INDV IndiviorUK£17.101.5%
+UK£32.9m
49.1%PE17x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AZN

UK£109.54

AstraZeneca

7D

0.3%

1Y

30.2%

EAH

UK£0.88

ECO Animal Health Group

7D

-1.7%

1Y

-42.4%

APH

UK£0.43

Alliance Pharma

7D

-27.3%

1Y

-57.3%

SAR

UK£0.88

Sareum Holdings

7D

1.7%

1Y

-70.3%

DPH

UK£27.62

Dechra Pharmaceuticals

7D

1.2%

1Y

-45.4%

STX

UK£0.10

Shield Therapeutics

7D

-12.8%

1Y

-69.4%

OCTP

UK£0.0055

Oxford Cannabinoid Technologies Holdings

7D

-4.3%

1Y

-71.8%

IMM

UK£0.023

ImmuPharma

7D

-9.0%

1Y

-65.5%

HCM

UK£1.80

HUTCHMED (China)

7D

-2.3%

1Y

-66.2%

GSK

UK£13.92

GSK

7D

1.8%

1Y

-26.3%

FUM

UK£0.42

Futura Medical

7D

6.2%

1Y

33.2%

CEL

UK£0.53

Celadon Pharmaceuticals

7D

2.9%

1Y

n/a

ANCR

UK£2.25

Animalcare Group

7D

-4.3%

1Y

-34.2%

HIK

UK£15.23

Hikma Pharmaceuticals

7D

6.6%

1Y

-33.1%

POLB

UK£0.093

Poolbeg Pharma

7D

-9.2%

1Y

-4.1%